dexrazoxane has been researched along with Soft Tissue Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Busemann, C; Ehninger, G; Gerdes, S; Hentschel, L; Kopp, HG; Lenz, F; Pink, D; Reichardt, P; Richter, S; Schuler, MK; West, A | 1 |
1 other study(ies) available for dexrazoxane and Soft Tissue Neoplasms
Article | Year |
---|---|
Efficacy and safety of Dexrazoxane (DRZ) in sarcoma patients receiving high cumulative doses of anthracycline therapy - a retrospective study including 32 patients.
Topics: Adolescent; Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Cardiotoxicity; Dexrazoxane; Disease-Free Survival; Female; Free Radical Scavengers; Heart; Humans; Male; Middle Aged; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Young Adult | 2016 |